Biologic and immunogenic properties of langat tp 21 virus mouse macacus rhesus human non pathogenic in humans immunity against tick borne encephalitis live vaccine
Smorodintsev, A.A.; Ilyenko, V.I.; Platonov, V.G.
Japanese Journal of Medical Science and Biology 20(SUPP): 132-137
1967
Accession: 024241447
Full Text Article emailed within 1 workday: $29.90
Related References
Il'enko, V.I.; Davidenko, Z.B.; Smorodintsev, A.A. 1967: Further research on vaccine strains suitable for developing live vaccines against tick-borne encephalitis. Reactogenic and immunogenic properties of the Malayan virus Langate TP-21. used as a live vaccine against tick-borne encephalitis Tr Inst Eksp Med Akad Med Nauk Sssr 9(5): 138-146Pletnev, A.G.; Bray, M.; Hanley, K.A.; Speicher, J.; Elkins, R. 2001: Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes Journal of Virology 75(17): 8259-8267
Platonov, V.G. 1968: Experience in the study of a live vaccine made from the tp 21 strain of malayan langat virus rhesus monkey human tick borne encephalitis Bulletin Of The World Health Organization: 425-431
Tsetsarkin, K.A.; Maximova, O.A.; Liu, G.; Kenney, H.; Teterina, N.L.; Pletnev, A.G. 2019: Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus Mbio 10(2)
Mayer, V. 1975: A live vaccine against tick-borne encephalitis: integrated studies. I. Basic properties and behaviour of the E5 "14" Clone (Langat virus) Acta Virologica 19(3): 209-218
Il'enko, V.I.; Platonov, V.G.; Prozorova, I.N.; Smorodintsev, A.A. 1989: The possibility of preparing a live vaccine against tick-borne encephalitis from Malay langat virus TP-21 Trudy Instituta Imeni Pastera 65: 126-132
Tesarová-Mágrová, J. 1972: The electrocardiographic patterns in patients with a tick-borne encephalitis and in Macacus rhesus monkeys infected with the Czechoslovak strain of the tick-borne encephalitis virus Acta Universitatis Carolinae. Medica 18(5-6): 243-291
Mayer, V.; Orolin, D.; Pogády, J.; Stárek, M.; Kubistová, K.; Gajdosová, E.; Buran, I. 1976: Experimental live tick-borne encephalitis vaccine (Labgat E5 "14" virus clone): volunteers 1 and 2 years after single-dose immunization Acta Virologica 20(3): 215-225
Wright, P.F.; Ankrah, S.; Henderson, S.E.; Durbin, A.P.; Speicher, J.; Whitehead, S.S.; Murphy, B.R.; Pletnev, A.G. 2008: Evaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers Vaccine 26(7): 882-890
Silber, L.A.; Shubladze, A.K. 1945: On the susceptibility of Macacus rhesus to the virus of tick-borne encephalitis American Review of Soviet Medicine 24: 332-338
Pripuzova, N.S.; Tereshkina, N.V.; Gmyl, L.V.; Dzhivanyan, T.I.; Rumyantsev, A.A.; Romanova, L.I.; Mustafina, A.N.; Lashkevich, V.A.; Karganova, G.G. 2009: Safety evaluation of chimeric Langat/Dengue 4 flavivirus, a live vaccine candidate against tick-borne encephalitis Journal of Medical Virology 81(10): 1777-1785
Andzhaparidze, O.G.; Stepanova, L.G.; Rozina, E.E. 1967: Study of variability of tick-borne encephalitis virus. IV. Pathogenic properties of some strains of tick-borne encephalitis group of viruses and their variants Vop Virusol 12(6): 691-697
Andzhaparidze, O.G.; Stepanova, L.G.; Rozina, E.E. 1967: A study of the mutability of tick-borne encephalitis virus. 4. Pathogenic properties of various strains of the tick-borne encephalitis group and their variants Voprosy Virusologii 12(6): 691-697
Slonim, D.; Závadová, H. 1977: Viremia and serum antibodies in Macacus rhesus monkey after inapparent infection with European tick-borne encephalitis virus Journal of Hygiene Epidemiology Microbiology and Immunology 21(4): 460-464
Danes, L.; Benda, R. 1960: Study of the possibility of preparing a vaccine against tick-borne encephalitis, using tissue culture methods. II. the inactivation by formaldehyde of the tickborne encephalitis virus in liquids prepared from tissue cultures. Immunogenic properties Acta Virologica 4: 82-93
Il'enko, V.I.; Smorodintsev, A.A.; David Enko, Z.B. 1965: Preliminary data from a test of the reactogenic and immunogenic prop-erties of a live vaccine against tick-borne encephalitis Tr Inst Poliomielita Virus Entsefalitov Akad Med Nauk Sssr 7: 412-421
Mayer, V.; Pogády, J.; Starek, M.; Hrbka, J. 1975: A live vaccine against tick-born encephalitis: integrated studies. III. Response of man to a single dose of the E5 "14" clone (Langat virus) Acta Virologica 19(3): 229-236
Tsetsarkin, K.A.; Liu, G.; Shen, K.; Pletnev, A.G. 2016: Kissing-loop interaction between 5' and 3' ends of tick-borne Langat virus genome 'bridges the gap' between mosquito- and tick-borne flaviviruses in mechanisms of viral RNA cyclization: applications for virus attenuation and vaccine development Nucleic Acids Research 44(7): 3330-3350
Turell, M.J.; Durden, L.A. 1994: Experimental transmission of Langat (tick-borne encephalitis virus complex) virus by the soft tick Ornithodoros sonrai (Acari: Argasidae) Journal of Medical Entomology 31(1): 148-151
Ilyenko, V.I.; Zhilova, G.P. 1963: Methods of preparation and immunogenic properties of a killed tissue culture vaccine against tick-borne encephalitis Acta Virol 7(1): 54-60